P95

P95 is a global, science-led Contract Research Organization (CRO) specializing in epidemiology, pharmacovigilance, and clinical trial solutions with a deep focus on vaccines and infectious diseases. The company provides end-to-end services, including study design, data management, biostatistics, and regulatory medical writing, supporting clients from early-phase development through post-marketing surveillance. Headquartered in Belgium, P95 has expanded its global footprint through strategic acquisitions and mergers, including the 2025 merger with Julius Clinical to form a unified, science-led platform. The company operates on five continents, leveraging localized expertise to conduct research in diverse settings, including underserved regions and LMICs, to advance global health outcomes.